This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by PACE, C. S. Articles by SMITH, J. S. Search for Related Content PubMed PubMed Citation Articles by PACE, C. S. Articles by SMITH, J. S.

The Role of Chemiosmotic Lysis in the Exocytotic Release of Insulin^*

CAROLINE S. PACE and JOEL S. SMITH

Department of Physiology and Biophysics and Diabetes Research and Training Hospital, University of Alabama Birmingham, Alabama 35294

Address all correspondence and requests for reprints to: Dr. Caroline S. Pace, Diabetes Hospital, University of Alabama, Birmingham, Alabama 35294.

Abstract

The role of chemiosmotic lysis in the exocytotic release of insulin has been studied using perifused rat pancreatic islets of Langerhans. Established criteria for osmotic lysis of secretory granules requires proton translocation across the secretory granule membrane and the influx of a permeant anion. The consequent increase in granule osmolarity induces water entry and granule lysis. A proton gradient has been previously established to exist across the insulin secretory granule membrane. We have examined the sensitivity of insulin release to 1) hyperosmolar solutions, 2) replacement of medium Cl^–, 3) replacement of medium Na⁺, and 4) anion transport inhibitors. The addition of 200–600 mM sucrose resulted in a 32–69% inhibition of insulin release due to 16.7 mM glucose. Replacement of Cl^– by isethionate or SO₄^— reversibly inhibited glucoseinduced insulin release by 47% and 78%, respectively. Na⁺ replacement by choline did not influence the secretory response. 4,4'-Diisothiocyano-2,2'-stilbene disulfonic acid (500 µM) and probenecid (10 mM) inhibited insulin release by 73% and 79%, respectively. These drugs are known to inhibit anion exchange in erythrocytes and may be influencing Cl^– entry into the secretory granule fused to the plasma membrane by a similar mechanism. Furosemide inhibits NaKCl₂ cotransport in erythrocytes, but had no influence on glucose-induced insulin release, suggesting that Cl^– does not enter the secretory granule by this pathway. The primary criteria for the participation of a chemiosmotic mechanism subserving lysis of the insulin secretory granule are fulfilled by these results. (Endocrinology 113: 964, 1983)

Footnotes

^* This work was supported by NIH Grant AM-21973.

Recipient of Research Career Development Award AM-00499.

Supported by the Diabetes Trust Fund.

Received January 13, 1983.